MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1248/yakushi.24-00145

Медицинская библиотека · Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan · 2024

[New Therapeutic Targets and Drugs for the Severe Asthma].

Kawano Tasuku

СтатьяОбзорАннотация на английскомПеревод в очереди

Аннотация

Bronchial asthma is primarily caused by sensitization to specific antigens that activate type 2 helper T cells (Th2) through acquired immunity, leading to chronic inflammation due to eosinophilic infiltration. Consequently, inhaled steroids have become an established standard treatment. However, refractory cases that do not respond to this treatment pose a challenge. Recent studies have revealed that neutrophils and type-2 innate lymphoid cells (ILC2) are steroid-resistant. The association between these cells and refractory severe asthma has garnered considerable attention. Therefore, my research focused on investigating the interplay among neuro-endocrine, -immune, and -epithelial cells to understand the pathology of refractory asthma, particularly steroid resistance, and to develop therapeutic medications. So far, I have elucidated the mechanism of the onset of neutrophilic airway inflammation due to stress and discovered the role of interleukin-1β, which could be a therapeutic target. Additionally, I have investigated the activation of ILC2 by pulmonary neuroendocrine cells, the release of calcitonin gene-related peptide (CGRP), and the efficacy of treatments for this condition. In this review, I outline treatment targets and approaches from a novel perspective to address severe refractory asthma focusing on my research findings.

Для цитирования: Kawano Tasuku. [New Therapeutic Targets and Drugs for the Severe Asthma].. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2024. DOI: 10.1248/yakushi.24-00145.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.